Protease-Activated Receptor 2 Sensitizes the Capsaicin Receptor Transient Receptor Potential Vanilloid Receptor 1 to Induce Hyperalgesia
Silvia Amadesi(University of California, San Francisco), Nigel W. Bunnett(University of California, San Francisco), Chiara Manni(University of Calgary), Emeran A. Mayer(University of California, Los Angeles), Graeme S. Cottrell(University of California, San Francisco), Helena S. Ennes(University of California, Los Angeles), Jingjiang Nie(University of California, Los Angeles), Marcello Trevisani(University of Ferrara), John B. Davis(GlaxoSmithKline (United Kingdom)), James A. McRoberts(University of California, Los Angeles), Pierangelo Geppetti(Azienda Ospedaliero-Universitaria Careggi), Eileen F. Grady(University of California, San Francisco), Nathalie Vergnolle(Digestive Health Research Institute)
Cited by 409
Related Papers
Gut/brain axis and the microbiota
|Journal of Clinical Investigation|2015|1.4k
Consumption of Fermented Milk Product With Probiotic Modulates Brain Activity
|Gastroenterology|2013|1.2k
Irritable bowel syndrome
|Nature Reviews Disease Primers|2016|981
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
|Proceedings of the National Academy of Sciences|2002|963
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
|Nature Medicine|2000|931